Prosecution Insights
Last updated: August 06, 2026

Silk Road Medical Inc.

5 pending office actions • 1 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready

Portfolio Summary

5
Total Pending OAs
3
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
1
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (40%)
2
Medium (40%)
1
Easy (20%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (20%)
§103 only2 (40%)
Double-patenting only1 (20%)
Multi-statute (no §101)1 (20%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
4
Mechanical / Eng
80% of docket
1
Business / Other
20% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

50 h
Manual time on pending OAs
10 h
Time saved (low, 20%)
18 h
Time saved (mid, 35%)
0.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MENDEZ, KATHERINE H 1 67.5% +33.5%
TON, MARTIN TRUYEN 1 61.8% +35.0%
RESTAINO, ANDREW PETER 1 72.7% +41.5%
TANNER, JOCELIN C 1 72.0% +35.1%
MCGRATH, ERIN E 1 60.0% +29.6%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18868987 TELESCOPING VASCULAR SHEATH SYSTEMS AND METHODS RESTAINO, ANDREW PETER 7d
18992667 METHODS AND DEVICES FOR CREATING CENTERED ARTERIOTOMY THROUGH CONDUIT TON, MARTIN TRUYEN

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18868987 TELESCOPING VASCULAR SHEATH SYSTEMS AND METHODS RESTAINO, ANDREW PETER 7d
19073501 SUTURE DELIVERY DEVICE MENDEZ, KATHERINE H
18992667 METHODS AND DEVICES FOR CREATING CENTERED ARTERIOTOMY THROUGH CONDUIT TON, MARTIN TRUYEN
18921676 METHODS AND SYSTEMS FOR TREATMENT OF ACUTE ISCHEMIC STROKE TANNER, JOCELIN C
18849433 METHODS AND DEVICES OF ACCESS SHEATH SYSTEMS MCGRATH, ERIN E

Top Art Units

Art UnitApps
3771 4

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19073501 SUTURE DELIVERY DEVICE MENDEZ, KATHERINE H DP Non-Final OA Pending Mar 07, 2025
18992667 METHODS AND DEVICES FOR CREATING CENTERED ARTERIOTOMY THROUGH CONDUIT TON, MARTIN TRUYEN 3771 §101§102§103§112 Non-Final OA Pending Jan 09, 2025
18868987 TELESCOPING VASCULAR SHEATH SYSTEMS AND METHODS RESTAINO, ANDREW PETER 3771 §102§103 Final Rejection 7d Pending Nov 25, 2024
18921676 METHODS AND SYSTEMS FOR TREATMENT OF ACUTE ISCHEMIC STROKE TANNER, JOCELIN C 3771 §103 Final Rejection Pending Oct 21, 2024
18849433 METHODS AND DEVICES OF ACCESS SHEATH SYSTEMS MCGRATH, ERIN E 3771 §103 Non-Final OA Pending Sep 20, 2024

Managing Silk Road Medical Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month